Living with SMA: Spotlight on the Policy and Access Environment in Europe

• Life Sciences
• CRA Insights

World Orphan Drug Congress Europe 2024 Review: 3 Themes for sustainable and equitable access to medicines for RD patients

This year’s European World Orphan Drug Congress, attended by CRA’s Bhavesh Patel, Michele Pistollato, Charlotte Poon, Owen Male and Clara Zacharko in...

• Life Sciences
• Reports

The economic cost of living with a rare disease across Europe

Although rare diseases affect a relatively small number of patients, collectively there are an estimated 30 million people in Europe living with 6,000-7,000...

• Life Sciences
• CRA Hosted Event

• January 14, 2025
• San Francisco, CA

JP Morgan Panel Discussion - Navigating the New Landscape: What will happen with prices?

It’s been a little over two years since the Inflation Reduction Act (IRA) was enacted. During this period, the first ten products have been negotiated with...